Suppr超能文献

拉贝洛尔用于顽固性高血压

Labetalol in resistant hypertension.

作者信息

Hedstrand H

出版信息

Acta Med Scand Suppl. 1982;665:125-8. doi: 10.1111/j.0954-6820.1982.tb00421.x.

Abstract

In 12 patients with resistant hypertension labetalol was added to existing therapy. The average dose was 1333 mg (range 400--3600). The subjects were followed up for three and a half years. Mean supine blood pressure (BP) was reduced from 202/123 to 163/103 mm Hg and mean standing BP from 193/127 to 144/100 mm Hg. Mean BP after exercise was 134/93 mm Hg. The main side-effect was postural hypotension during exercise, causing withdrawal of labetalol in two subjects. In patients with severe hypertension, resistant to several combinations of antihypertensive drugs, the addition of labetalol may lead to satisfactory BP reduction, especially when combined with a potent diuretic.

摘要

在12例顽固性高血压患者中,在现有治疗方案基础上加用拉贝洛尔。平均剂量为1333毫克(范围400 - 3600毫克)。对这些受试者进行了三年半的随访。平均仰卧位血压从202/123毫米汞柱降至163/103毫米汞柱,平均站立位血压从193/127毫米汞柱降至144/100毫米汞柱。运动后的平均血压为134/93毫米汞柱。主要副作用是运动期间的体位性低血压,导致两名受试者停用拉贝洛尔。在对多种抗高血压药物联合治疗耐药的重度高血压患者中,加用拉贝洛尔可能会使血压得到满意降低,尤其是与强效利尿剂联合使用时。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验